These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31939698)

  • 1. Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.
    Baikpour M; Ozturk A; Dhyani M; Mercaldo ND; Pierce TT; Grajo JR; Samir AE
    AJR Am J Roentgenol; 2020 Apr; 214(4):786-791. PubMed ID: 31939698
    [No Abstract]   [Full Text] [Related]  

  • 2. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.
    Angulo P; Bugianesi E; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Barrera F; Haflidadottir S; Day CP; George J
    Gastroenterology; 2013 Oct; 145(4):782-9.e4. PubMed ID: 23860502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the diagnostic accuracy of noninvasive scoring tools in predicting moderate-to-severe steatohepatitis via ultrasonography in asymptomatic healthy subjects admitted to family medicine outpatient clinics.
    Mert A
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6530-6538. PubMed ID: 37522664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Portal Venous and Hepatic Artery Haemodynamic Variation in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients.
    Balasubramanian P; Boopathy V; Govindasamy E; Venkatesh BP
    J Clin Diagn Res; 2016 Aug; 10(8):TC07-10. PubMed ID: 27656524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of portal vein doppler indices and hepatic vein doppler waveform in patients with nonalcoholic fatty liver disease with healthy control.
    Solhjoo E; Mansour-Ghanaei F; Moulaei-Langorudi R; Joukar F
    Hepat Mon; 2011 Sep; 11(9):740-4. PubMed ID: 22235218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease.
    Xu HW; Hsu YC; Chang CH; Wei KL; Lin CL
    Hepatol Int; 2016 Mar; 10(2):340-6. PubMed ID: 26676626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Six Noninvasive Methods for the Detection of Fibrosis in Chinese Patients with Obesity and Nonalcoholic Fatty Liver Disease.
    Chen G; Yang JC; Zhang GX; Cheng Z; Du X
    Obes Surg; 2022 Nov; 32(11):3619-3626. PubMed ID: 36070119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.
    Pérez-Gutiérrez OZ; Hernández-Rocha C; Candia-Balboa RA; Arrese MA; Benítez C; Brizuela-Alcántara DC; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2013; 12(3):416-24. PubMed ID: 23619258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow pulsatility in the portal venous system: a study of Doppler sonography in healthy adults.
    Gallix BP; Taourel P; Dauzat M; Bruel JM; Lafortune M
    AJR Am J Roentgenol; 1997 Jul; 169(1):141-4. PubMed ID: 9207514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
    Nasr P; Hilliges A; Thorelius L; Kechagias S; Ekstedt M
    Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease.
    Hagström H; Nasr P; Ekstedt M; Stål P; Hultcrantz R; Kechagias S
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1148-1156.e4. PubMed ID: 30471458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease.
    Lee J; Choi S; Cho SH; Yang H; Sung PS; Bae SH
    Diagnostics (Basel); 2024 Feb; 14(4):. PubMed ID: 38396432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience.
    Rath MM; Panigrahi MK; Pattnaik K; Bhuyan P; Kar SK; Misra B; Misra D; Meher C; Agrawal O; Rath J; Singh SP
    J Clin Exp Hepatol; 2016 Dec; 6(4):291-296. PubMed ID: 28003718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy.
    Mikolasevic I; Domislovic V; Krznaric-Zrnic I; Krznaric Z; Virovic-Jukic L; Stojsavljevic S; Grgurevic I; Milic S; Vukoja I; Puz P; Aralica M; Hauser G
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208576
    [No Abstract]   [Full Text] [Related]  

  • 16. Portal vein hemodynamics in patients with non-alcoholic fatty liver disease.
    Erdogmus B; Tamer A; Buyukkaya R; Yazici B; Buyukkaya A; Korkut E; Alcelik A; Korkmaz U
    Tohoku J Exp Med; 2008 May; 215(1):89-93. PubMed ID: 18509239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease.
    Yang M; Jiang L; Wang Y; Li X; Zou Z; Han T; Nan Y; Lu F; Zhao J
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):289-296. PubMed ID: 31517325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.
    Yoneda M; Imajo K; Eguchi Y; Fujii H; Sumida Y; Hyogo H; Ono M; Suzuki Y; Kawaguchi T; Aoki N; Sata M; Kanemasa K; Kohgo Y; Saibara T; Chayama K; Itoh Y; Yoshikawa T; Anzai K; Fujimoto K; Okanoue T; Nakajima A;
    J Gastroenterol; 2013 Sep; 48(9):1051-60. PubMed ID: 23184095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
    Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.